K-numberK251268
Device nameDiagnostic Ultrasound System (Nano C5, Nano C5 EXP, Nano L12, and Nano L12 EXP)
ApplicantEdan Instruments, Inc.
Product codeIYN
Device classClass II
Decision dateDec 23, 2025
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Nano Series Diagnostic Ultrasound System is a portable ultrasound imaging device consisting of an app installable on iOS or Android devices paired with convex and linear transducers using wired or wireless communication. It is intended for use by trained healthcare professionals in hospitals, clinics, ambulances, or homes for diagnostic ultrasound evaluation across multiple clinical applications including abdominal, gynecologic, obstetric, cardiac, musculoskeletal, and vascular imaging.

Technological characteristics

The Nano Series offers B mode, M mode, Doppler modes, and Harmonic Imaging with combination modes, supporting dual imaging, speckle reduction imaging (eSRI), auto trace, zoom, ECG wave, eVocal, eWorks, and remote diagnosis features. The system is comparable to the predicate Lumify device but with a narrower set of explicitly listed clinical applications, though the imaging modes and measurement capabilities (distance, circumference, area, angle, velocity, heart rate) are substantially identical.

Test standards cited

Testing per IEC 60601-1:2005+A1:2012+A2:2020 (general medical electrical equipment safety), IEC 60601-1-2:2014+A1:2020 (electromagnetic compatibility), IEC 60601-2-37:2007+A1:2015 (ultrasonic diagnostic equipment), IEC 60601-1-11:2015+A1:2020 (home healthcare environment), and IEC 60601-1-12:2014+A1:2020 (emergency medical services). FDA guidance documents on marketing clearance of diagnostic ultrasound systems and device software functions were also applied.

Substantial equivalence argument

The Nano Series is substantially equivalent to the Philips Lumify predicate device because both employ identical ultrasound imaging technology, support the same core imaging modes (B, Doppler, M, Harmonic), use iOS/Android platforms, offer identical measurement functions, include rechargeable batteries, and are portable diagnostic systems. Bench testing and software verification/validation demonstrated the subject device meets relevant consensus standards and is as safe and effective as the predicate, with no technological differences that raise different safety or effectiveness questions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →